These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5322895)

  • 21. Bactericidal activity of fluoroquinolones against plasmid-mediated QnrA-producing Escherichia coli.
    Mammeri H; Poirel L; Nordmann P
    Clin Microbiol Infect; 2005 Dec; 11(12):1048-9. PubMed ID: 16307564
    [No Abstract]   [Full Text] [Related]  

  • 22. Mode of action of prasinomycin.
    Laskin AI; Chan WM; Smith DA; Meyers E
    Antimicrob Agents Chemother (Bethesda); 1967; 7():251-6. PubMed ID: 5596146
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Aminotetralones: novel inhibitors of MurA and MurZ.
    Dunsmore CJ; Miller K; Blake KL; Patching SG; Henderson PJ; Garnett JA; Stubbings WJ; Phillips SE; Palestrant DJ; Angeles Jde L; Leeds JA; Chopra I; Fishwick CW
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1730-4. PubMed ID: 18261901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
    Wojnicz D; Cisowska A
    Int J Antimicrob Agents; 2009 Jun; 33(6):579-82. PubMed ID: 19232480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal properties of silica particles with silver islands located on the surface.
    Bugla-Płoskońska G; Leszkiewicz A; Borak B; Jasiorski M; Drulis-Kawa Z; Baszczuk A; Maruszewski K; Doroszkiewicz W
    Int J Antimicrob Agents; 2007 Jun; 29(6):746-8. PubMed ID: 17275262
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems.
    Fernandes JC; Tavaria FK; Soares JC; Ramos OS; João Monteiro M; Pintado ME; Xavier Malcata F
    Food Microbiol; 2008 Oct; 25(7):922-8. PubMed ID: 18721683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A common mechanism of cellular death induced by bactericidal antibiotics.
    Kohanski MA; Dwyer DJ; Hayete B; Lawrence CA; Collins JJ
    Cell; 2007 Sep; 130(5):797-810. PubMed ID: 17803904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coli.
    Stubbings WJ; Bostock JM; Ingham E; Chopra I
    J Antimicrob Chemother; 2004 Jul; 54(1):139-43. PubMed ID: 15150167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the antibacterial activity of phanquone: chelating properties in relation to mode of action against Escherichia coli and Staphylococcus aureus.
    Husseini R; Stretton RJ
    Microbios; 1980; 29(116):109-25. PubMed ID: 7022141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth-inhibitory activities of some 1,4-naphthoquinones and related compounds on Staphylococcus aureus and Escherichia coli.
    Leahy GJ; Currie DJ; Holmes HL; Maltman JR
    Can J Microbiol; 1968 Jun; 14(6):661-6. PubMed ID: 4874787
    [No Abstract]   [Full Text] [Related]  

  • 33. Mode of action of coumermycin A: comparisons with novobiocin.
    Michaeli D; Molavi A; Mirelman D; Hanoch A; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1970; 10():95-9. PubMed ID: 5521380
    [No Abstract]   [Full Text] [Related]  

  • 34. Bactericidal mechanism of Ag/Al2O3 against Escherichia coli.
    Chang Q; Yan L; Chen M; He H; Qu J
    Langmuir; 2007 Oct; 23(22):11197-9. PubMed ID: 17902710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial effect of nitric oxide].
    Coban AY; Bayramoğlu G; Ekinci B; Durupinar B
    Mikrobiyol Bul; 2003; 37(2-3):151-5. PubMed ID: 14593897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical aspects of hydrophobic polycationic bactericidal "paints".
    Mukherjee K; Rivera JJ; Klibanov AM
    Appl Biochem Biotechnol; 2008 Oct; 151(1):61-70. PubMed ID: 18327545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Filtering, bactericidal and bacteriostatic action of soda lime].
    Consorti P; Giomarelli PP
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1429-32. PubMed ID: 5760382
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the mechanisms of action on the bacterial cell of a new antimicrobial drug: nifurzide (author's transl)].
    Videz S; Perrier J; Gounot AM
    Ann Pharm Fr; 1981; 39(5):451-62. PubMed ID: 7034623
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on mechanism of action of bruneomycin].
    Dudnik IuV; Gauze GG
    Antibiotiki; 1965 Oct; 10(10):880-5. PubMed ID: 5333599
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.
    Sahm DF; Marsilio MK; Piazza G
    Clin Infect Dis; 1999 Aug; 29(2):259-63. PubMed ID: 10476722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.